Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury.

Journal of immunology research - 1 Jan 2015

Rowart Pascal, Erpicum Pauline, Detry Olivier, Weekers Laurent, Grégoire Céline, Lechanteur Chantal, Briquet Alexandra, Beguin Yves, Krzesinski Jean-Marie, Jouret François

Abstract excerpt

Ischemia/reperfusion injury (IRI) represents a worldwide public health issue of increasing incidence. IRI may virtually affect all organs and tissues and is associated with significant morbidity and mortality. Particularly, the duration of blood supply deprivation has been recognized as a critica...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to Brain Ischemia
Share to Cell- and Tissue-Based Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Diseases

Share to Liver Diseases

Share to Mesenchymal Stem Cell Transplantation

Share to Myocardial Reperfusion Injury

Share to Reperfusion Injury

Source

Open in PubMed Open full text

Identifiers

PMID: 26258151
DOI: 10.1155/2015/602597
PMCID: PMC4518154

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26258151-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury.PMID 26258151Read ↗

Mesenchymal stromal cell therapy in ischemic heart disease.Semantic proximity Read ↗

Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart DiseaseSemantic proximity Read ↗

Clinical translation of mesenchymal stem cells in ischemic heart failure: Challenges and future perspectivesSemantic proximity Read ↗

Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarctionSemantic proximity Read ↗

Use of mesenchymal stem cells for therapy of cardiac disease.Semantic proximity Read ↗

Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarctionSemantic proximity Read ↗

Concise Review: Immunomodulatory Properties of Mesenchymal Stem Cells in Cellular Transplantation: Update, Controversies, and UnknownsSemantic proximity Read ↗

Potential of mesenchymal stem cell therapy.Semantic proximity Read ↗

Hypoxia-Mediated Molecular Interactions of Tissue-Specific Mesenchymal Stem Cells Drive Metabolic Reprogramming and Immunomodulation in Acute Graft-versus-Host DiseaseSemantic proximity Read ↗

Mesenchymal stem cells and cardiac repair: principles and practice.Semantic proximity Read ↗

Regeneration-Associated Cells Improve Recovery from Myocardial Infarction through Enhanced Vasculogenesis, Anti-inflammation, and CardiomyogenesisSemantic proximity Read ↗

Transplantation of Immortalized CD34+ and CD34- Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory Responses.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.